Yuen, M. F. et al. Hepatitis B virus infection. Nat. Rev. Dis. Primers 4, 18035 (2018).
Iannacone, M. & Guidotti, L. G. Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22, 19–32 (2022).
Article CAS PubMed Google Scholar
Sung, W. K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 44, 765–769 (2012).
Article CAS PubMed Google Scholar
Tu, T., Budzinska, M. A., Vondran, F. W. R., Shackel, N. A. & Urban, S. Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles. J. Virol. https://doi.org/10.1128/JVI.02007-17 (2018).
Article PubMed PubMed Central Google Scholar
Shiffman, M. L. Management of acute hepatitis B. Clin. Liver Dis. 14, 75–91 (2010).
Hyams, K. C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 20, 992–1000 (1995).
Article CAS PubMed Google Scholar
Tong, S. & Revill, P. Overview of hepatitis B viral replication and genetic variability. J. Hepatol. 64, S4–S16 (2016).
Article CAS PubMed PubMed Central Google Scholar
Hsu, Y. S. et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35, 1522–1527 (2002).
Nguyen, L. H., Chao, D., Lim, J. K., Ayoub, W. & Nguyen, M. H. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review. Clin. Gastroenterol. Hepatol. 12, 1262–1266 (2014).
Article CAS PubMed Google Scholar
Huang, D. Q. et al. Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase. Clin. Gastroenterol. Hepatol. 20, 1803–1812.e5 (2022).
Article CAS PubMed Google Scholar
Huang, Y. T. et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J. Clin. Oncol. 29, 3643–3650 (2011).
Article PubMed PubMed Central Google Scholar
McMahon, B. J. Natural history of chronic hepatitis B. Clin. Liver Dis. 14, 381–396 (2010).
World Health Organization. Global Hepatitis Report 2017 (World Health Organization, 2017).
World Health Organization. Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022–2030 (World Health Organization, 2022).
Nayagam, S. et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect. Dis. 16, 1399–1408 (2016).
Blach, S. et al. Evaluation of global progress towards HBV and HCV elimination. J. Hepatol. 77, S230–S231 (2022).
Razavi-Shearer, D. et al. The disease burden of hepatitis B and hepatitis C from 2015 to 2030: the long and winding road [Abstract OS050]. J. Hepatol. 77, S43 (2022).
World Health Organization. Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections 2021. WHO https://www.who.int/publications/i/item/9789240027077 (2021).
World Health Organization. Hepatitis B. WHO https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (2021).
Beasley, R. P. et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J. Infect. Dis. 146, 198–204 (1982).
Article CAS PubMed Google Scholar
Chang, K. C. et al. Universal infant hepatitis B virus (HBV) vaccination for 35 years: moving toward the eradication of HBV. J. Infect. Dis. 225, 431–435 (2022).
Article CAS PubMed Google Scholar
Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3, 383–403 (2018).
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).
Schmit, N., Nayagam, S., Thursz, M. R. & Hallett, T. B. The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups. Int. J. Epidemiol. 50, 560–569 (2021).
de Villiers, M. J. et al. Modelling hepatitis B virus infection and impact of timely birth dose vaccine: a comparison of two simulation models. PLoS ONE 15, e0237525 (2020).
Article PubMed PubMed Central Google Scholar
Simonetti, J. et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 51, 1531–1537 (2010).
Huang, D. Q. & Lim, S. G. Life after s loss: impact of hepatitis B s antigen loss on future patient outcomes. Clin. Liver Dis. 16, 262–265 (2020).
Wong, D. K. et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology 54, 829–836 (2011).
Article CAS PubMed Google Scholar
Covolo, L., Pollicino, T., Raimondo, G. & Donato, F. Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis. Dig. Liver Dis. 45, 238–244 (2013).
The World Bank. World Bank Country and Lending Groups. The World Bank https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (2022).
United Nations Conference on Trade and Development. List of Least Developed Countries. UNCTAD https://unctad.org/topic/least-developed-countries/map (2022).
European Centre for Disease Prevention and Control. Systematic Review on Hepatitis B and C Prevalence in the EU/EEA. ECDC https://www.ecdc.europa.eu/en/publications-data/systematic-review-hepatitis-b-and-c-prevalence-eueea (2016).
Durro, V. & Qyra, S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999–2009. Virol. J. 8, 96 (2011).
Article PubMed PubMed Central Google Scholar
Gheorghe, L., Csiki, I. E., Iacob, S. & Gheorghe, C. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey. Eur. J. Gastroenterol. Hepatol. 25, 56–64 (2013).
Wong, R. J. et al. An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States. Hepatology 74, 607–626 (2021).
Rossi, C. et al. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS ONE 7, e44611 (2012).
Article CAS PubMed PubMed Central Google Scholar
Ahmad, A. A. et al. Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries. BMC Infect. Dis. 18, 34 (2018).
Article PubMed PubMed Central Google Scholar
Moutchia, J. et al. Maternal age at first childbirth and geographical variation in hepatitis B virus prevalence in Cameroon: important role of mother-to-child transmission. Clin. Infect. Dis. 74, 836–845 (2022).
Malabarey, O. T., Balayla, J., Klam, S. L., Shrim, A. & Abenhaim, H. A. Pregnancies in young adolescent mothers: a population-based study on 37 million births. J. Pediatr. Adolesc. Gynecol. 25, 98–102 (2012).
Lim, J. K. et al. Prevalence of chronic hepatitis B virus infection in the United States. Am. J. Gastroenterol. 115, 1429–1438 (2020).
Rashti, R. et al. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis. Arch. Virol. 165, 1947–1958 (2020).
Article CAS PubMed Google Scholar
Adane, T. & Getawa, S. The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: a systematic review and meta-analysis. PLoS ONE 16, e0251570 (2021).
Article CAS PubMed PubMed Central Google Scholar
Mokaya, J. et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection — a systematic review. Wellcome Open Res. 3, 29 (2018).
Article PubMed PubMed Central Google Scholar
Braveman, P. A., Cubbin, C., Egerter, S., Williams, D. R. & Pamuk, E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am. J. Public Health 100, S186–S196 (2010).
Article PubMed PubMed Central Google Scholar
Wong, G. L. et al. An aging population of chronic hepatitis B with increasing comorbidities: a territory-wide study from 2000 to 2017. Hepatology 71, 444–455 (2020).
留言 (0)